• AIDS Clinical Trials Unit celebrates 25 years of progress

    Volunteers, top researchers helped transform HIV/AIDS treatment

    December 8, 2017
    Debra Melani
    AIDS researchers at CU Anschutz
  • New blood spot test used internationally in fight against HIV

    Technique developed at University of Colorado Anschutz measures patient adherence to antiretroviral drugs

    August 23, 2016
    Nathan Gill
  • Healing power of ART in Zimbabwe

    Art therapy touches the lives of those with HIV/AIDS

    December 3, 2012
    Amanda Heersink
  • Facebook messages may prevent sexually transmitted infections

    Outreach through social media can encourage condom use

    October 9, 2012
    Jacque Montgomery
  • Use of HIV medications reduces risk of HIV infection in uninfected people

    Major study published in the New England Journal of Medicine demonstrates the effectiveness of a new HIV prevention tool, Pre-Exposure Prophylaxis (PrEP)

    In a finding with the potential to fundamentally change strategies to slow the global HIV epidemic, a new study called iPrEx shows that individuals at high risk for HIV infection who took a single daily tablet containing two widely used HIV medications, emtricitabine and tenofovir (FTC/TDF), experienced an average of 43.8 percent fewer HIV infections than those who received a placebo pill.… Full Story

    November 23, 2010
    Guest Contributor